KLA480
/ Sichuan Kelun Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 27, 2025
A Phase I Clinical Study of a Single Dose of KLA480
(clinicaltrials.gov)
- P1 | N=20 | Recruiting | Sponsor: Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
New P1 trial
1 to 1
Of
1
Go to page
1